Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1Classical hematology 1

Conditions

Neoplasms 518Breast Neoplasms 456Lung Neoplasms 252Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 185Pancreatic Neoplasms 154Carcinoma, Hepatocellular 136Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Melanoma 93Head and Neck Neoplasms 93Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 85Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 75Liver Neoplasms 74Hematologic Neoplasms 74Endometrial Neoplasms 71Leukemia, Myeloid, Acute 66Neoplasm Metastasis 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Sarcoma 53Leukemia 53Glioma 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × beta-Thalassemia × Clear all
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
Classical hematologyOtherPlasma cell

Alzheimer Disease, Amyloidosis, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Cystic Fibrosis, Ehlers-Danlos Syndrome, Gaucher Disease, Glycogen Storage Disease Type II, Huntington Disease, Myasthenia Gravis, Gangliosidosis, GM1, alpha-Thalassemia, beta-Thalassemia, Muscular Dystrophy, Duchenne, Insomnia, Fatal Familial, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡